Logo image of MSON

Misonix Inc (MSON) Stock Fundamental Analysis

USA - NASDAQ:MSON -

26.54
+1.2 (+4.74%)
Last: 10/28/2021, 8:55:53 PM
26.54
0 (0%)
After Hours: 10/28/2021, 8:55:53 PM
Fundamental Rating

2

Taking everything into account, MSON scores 2 out of 10 in our fundamental rating. MSON was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of MSON have multiple concerns. MSON is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MSON had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -7.28%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -14.91%
PM (TTM) -19.55%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

MSON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

MSON has an Altman-Z score of 4.27. This indicates that MSON is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.29 indicates that MSON is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z 4.27
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

MSON has a Current Ratio of 2.61. This indicates that MSON is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 1.92 indicates that MSON should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.61
Quick Ratio 1.92

More info and screens

5

3. Growth

3.1 Past

MSON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.00%, which is quite good.
MSON shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.47%.
The Revenue has been growing by 26.21% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48%
Revenue 1Y (TTM)18.47%
Revenue growth 3Y26.37%
Revenue growth 5Y26.21%
Sales Q2Q%43.55%

3.2 Future

MSON is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.37% yearly.
Based on estimates for the next years, MSON will show a quite strong growth in Revenue. The Revenue will grow by 15.97% on average per year.
EPS Next Y10.14%
EPS Next 2Y25.01%
EPS Next 3Y13.04%
EPS Next 5Y6.37%
Revenue Next Year16.14%
Revenue Next 2Y16.55%
Revenue Next 3Y15.78%
Revenue Next 5Y15.97%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MSON Yearly Revenue VS EstimatesMSON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
MSON Yearly EPS VS EstimatesMSON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2018 2019 2020 2021 2022 2023 2024 2025 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MSON. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MSON. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MSON Price Earnings VS Forward Price EarningsMSON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -80.24
MSON Per share dataMSON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as MSON's earnings are expected to grow with 13.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.01%
EPS Next 3Y13.04%

More info and screens

0

5. Dividend

5.1 Amount

MSON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Misonix Inc

NASDAQ:MSON (10/28/2021, 8:55:53 PM)

After market: 26.54 0 (0%)

26.54

+1.2 (+4.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)02-11 2022-02-11/amc
Inst Owners0%
Inst Owner Change-97.67%
Ins Owners7.59%
Ins Owner Change0%
Market Cap462.06M
Revenue(TTM)74.02M
Net Income(TTM)-14473400
Analysts60
Price Target28.56 (7.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.24
P/FCF N/A
P/OCF N/A
P/B 3.42
P/tB N/A
EV/EBITDA -80.24
EPS(TTM)-0.84
EYN/A
EPS(NY)-0.75
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.25
BVpS7.77
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.28%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -14.91%
PM (TTM) -19.55%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.61
Quick Ratio 1.92
Altman-Z 4.27
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48%
EPS Next Y10.14%
EPS Next 2Y25.01%
EPS Next 3Y13.04%
EPS Next 5Y6.37%
Revenue 1Y (TTM)18.47%
Revenue growth 3Y26.37%
Revenue growth 5Y26.21%
Sales Q2Q%43.55%
Revenue Next Year16.14%
Revenue Next 2Y16.55%
Revenue Next 3Y15.78%
Revenue Next 5Y15.97%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Misonix Inc / MSON FAQ

Can you provide the ChartMill fundamental rating for Misonix Inc?

ChartMill assigns a fundamental rating of 4 / 10 to MSON.


What is the valuation status for MSON stock?

ChartMill assigns a valuation rating of 2 / 10 to Misonix Inc (MSON). This can be considered as Overvalued.


Can you provide the profitability details for Misonix Inc?

Misonix Inc (MSON) has a profitability rating of 3 / 10.


How financially healthy is Misonix Inc?

The financial health rating of Misonix Inc (MSON) is 4 / 10.